Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
EZ Cap™ Firefly Luciferase mRNA Workflow
2026-08-19
Use a Cap1- and poly(A)-optimized reporter to separate mRNA delivery, translation, viability, and assay timing in cell and animal studies. This workflow shows how to benchmark LNP performance, build gene regulation reporter assays, and troubleshoot weak or variable bioluminescence without confusing reporter output with therapeutic efficacy.
-
SP600125: A Practical JNK Inhibitor Workflow
2026-08-19
SP600125 helps dissect how TLR2/TLR4 signals connect to JNK-driven cytokine production in monocyte inflammation models. This guide translates its biochemical selectivity into a practical workflow for pathway timing, cytokine expression modulation, apoptosis assay controls, and troubleshooting.
-
Self-Amplifying RNA Vaccines for Influenza: Study Insights
2026-08-18
A 2026 study found that self-amplifying RNA produced strong, durable, and dose-sparing protection against influenza B in mice, where conventional mRNA performed poorly. Its central contribution is a direct comparison of nucleoside-modified mRNA, self-amplifying RNA, and circular RNA platforms across influenza subtypes.
-
Fluorouracil: From DNA Stress to Immune Strategy
2026-08-18
A translational perspective on Fluorouracil (5-Fluorouracil, Adrucil), connecting thymidylate synthase inhibition and DNA replication stress with Wnt/β-catenin biology, immune context, and practical oncology research workflows.
-
Kir4.1–Panx3 Signaling in Orofacial Neuropathic Pain
2026-08-17
This study identifies a mechanistic link between reduced Kir4.1 activity in trigeminal satellite glial cells and Panx3-dependent orofacial neuropathic pain. Using chronic constriction injury of the infraorbital nerve, genetic manipulation, and ROS–p38 MAPK analyses, the authors position Panx3 downstream of a redox-sensitive glial signaling pathway.
-
XPO1 Inhibition Sensitizes GCB-DLBCL to Platinum
2026-08-17
A 2026 Hematology study shows that inhibiting XPO1 with selinexor increases the response of diffuse large B-cell lymphoma models to cisplatin and oxaliplatin. The strongest combination effects occurred in germinal-center B-cell-like DLBCL, where platinum-associated apoptosis, reactive oxygen species accumulation, DNA-damage signaling, and stress-response pathways were amplified.
-
Dinaciclib: From CDK Inhibition to Tissue Mechanics
2026-08-16
Explore how Dinaciclib and SCH727965 can support mechanistic cancer research beyond conventional cell-cycle assays. This article connects multi-CDK inhibition with apoptosis, Rb signaling, and the interpretation of tissue-boundary phenotypes revealed by quantitative developmental biology.
-
Dual-Action p38α Inhibitors and Dephosphorylation
2026-08-15
The reference study shows that selected kinase inhibitors can both suppress p38α catalytic activity and accelerate WIP1-mediated removal of the activation-loop phosphate. Biochemical measurements and X-ray structures connect this effect to stabilization of a phosphatase-accessible activation-loop conformation, suggesting a framework for designing more durable and selective kinase inhibitors.
-
Anisomycin Workflows for JNK Signaling Studies
2026-08-14
Anisomycin provides a practical pharmacological entry point for separating early JNK signaling from later cell death phenotypes. This guide covers concentration and timing screens, cancer-apoptosis applications, neurobiology extensions, and controls that prevent stress-response data from being overinterpreted.
-
Olaparib: A G4–PARP Combination Framework
2026-08-14
Olaparib and AZD2281 are examined as mechanistic tools for connecting PARP inhibition with the BLM G-quadruplex–STAT1 axis. This framework helps researchers design more informative DNA damage response assays, combination studies, and tumor radiosensitization experiments.
-
Astrocytic GAT-3 Controls Dentate Gyrus Memory
2026-08-13
Shen and colleagues show that astrocytic GAT-3 converts GABA uptake into a calcium-dependent signal that enhances dentate gyrus synaptic transmission through presynaptic GluN2B-containing NMDARs. The study connects this glial pathway to contextual fear memory and provides a mechanistic framework for synaptic transmission research and related in vitro neurotransmission assays.
-
Anisomycin, JNK Signaling, and Translational Strategy
2026-08-13
Anisomycin is more than a cytotoxicity reagent: it is a mechanistic JNK agonist that can help translational researchers connect stress signaling, apoptosis, and experimental decision-making. This article places its cancer biology applications alongside emerging lessons from social memory research while clearly separating established evidence from forward-looking hypotheses.
-
Acacetin, Mitophagy, and Pyroptosis in IVDD
2026-08-12
A 2025 Phytomedicine study identifies an acacetin-mediated MAPK1/HMOX1 pathway through which Duhuo Jisheng decoction enhances mitophagy and suppresses nucleus pulposus cell pyroptosis in intervertebral disc degeneration. Its integrated chemical, cellular, and animal-model design provides a useful framework for connecting traditional medicine components with mitochondrial quality control and inflammatory cell death.
-
Adefovir (GS-0393) in HBV Research
2026-08-12
Adefovir combines a mechanistically clear HBV polymerase readout with a useful OAT1 transporter application, enabling antiviral and renal-disposition workflows from one research tool. This guide covers dose-response design, aqueous handling, transporter kinetics, and interpretation of hypophosphatemia-related translational signals.
-
Dual-Action Inhibitors Reprogram p38α Dephosphorylation
2026-08-11
The 2024 preprint identifies kinase inhibitors that do more than suppress p38α catalytic signaling: they also accelerate WIP1-mediated removal of the activation-loop phosphothreonine. Biochemical measurements and X-ray structures suggest that inhibitor-stabilized activation-loop conformations expose the phosphatase substrate, providing a framework for designing kinase inhibitors that promote pathway shutdown through two coordinated mechanisms.